COHANCE LIFESCIENCES
Back to Balance Sheet
|
COHANCE LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹19 Cr | ₹18 Cr | ₹6.07 Cr | ₹6.07 Cr | ₹6.07 Cr |
What is the latest Contingent Liabilities ratio of COHANCE LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹6.07 Cr |
| Mar2022 | ₹6.07 Cr |
| Mar2021 | ₹6.07 Cr |
How is Contingent Liabilities of COHANCE LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | 3.53 | |
| Mar2024 | ₹18 Cr | 198.50 | |
| Mar2023 | ₹6.07 Cr | 0.00 | |
| Mar2022 | ₹6.07 Cr | 0.00 | |
| Mar2021 | ₹6.07 Cr | - | |
Compare Contingent Liabilities of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹16,937.7 Cr | -1.4% | 1.8% | -55.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | -1.4% |
1.8% |
-55.5% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses